Movatterモバイル変換


[0]ホーム

URL:


CN113717073B - Novel method for synthesizing minocycline hydrochloride - Google Patents

Novel method for synthesizing minocycline hydrochloride
Download PDF

Info

Publication number
CN113717073B
CN113717073BCN202110988351.8ACN202110988351ACN113717073BCN 113717073 BCN113717073 BCN 113717073BCN 202110988351 ACN202110988351 ACN 202110988351ACN 113717073 BCN113717073 BCN 113717073B
Authority
CN
China
Prior art keywords
hydrochloride
solvent
reaction
synthesizing
chloromountain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110988351.8A
Other languages
Chinese (zh)
Other versions
CN113717073A (en
Inventor
米祥忻
袁昉
王绘砖
宋志倩
常国栋
刘萌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEBEI SHENGXUE DACHENG PHARMACEUTICAL CO Ltd
Original Assignee
HEBEI SHENGXUE DACHENG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEBEI SHENGXUE DACHENG PHARMACEUTICAL CO LtdfiledCriticalHEBEI SHENGXUE DACHENG PHARMACEUTICAL CO Ltd
Priority to CN202110988351.8ApriorityCriticalpatent/CN113717073B/en
Publication of CN113717073ApublicationCriticalpatent/CN113717073A/en
Application grantedgrantedCritical
Publication of CN113717073BpublicationCriticalpatent/CN113717073B/en
Activelegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Classifications

Landscapes

Abstract

The invention provides a novel method for synthesizing minocycline hydrochloride, which comprises the following steps: A. taking hydrochloric acid demethyl aureomycin as a raw material, and carrying out debenzylation reaction on the raw material to obtain 7-chloromountain cyclic extract; B. 7-chloromountain cyclamine, sodium iodide or potassium iodide are used as raw materials, and an ultraviolet irradiation method is used for synthesizing 7-iodomountain cyclamine; C. taking 7-iodo-shan-cycline and an organotin reagent as raw materials, and carrying out a coupling reaction under the action of a palladium complex to produce minocycline hydrochloride. The method simplifies the steps of synthesizing minocycline hydrochloride, improves the safety of the reaction, reduces the labor hour cost and improves the feasibility of industrialized mass production.

Description

Novel method for synthesizing minocycline hydrochloride
Technical Field
The invention belongs to the technical field of organic synthesis of synthetic antibiotics, and particularly relates to a novel method for synthesizing minocycline hydrochloride.
Background
Minocycline hydrochloride, compound structure:
CAS number: 13614-98-7, molecular weight: 493.94.
minocycline hydrochloride is a broad-spectrum antibiotic with lasting acting force, belonging to the class of tetracyclines. The medicine is a rapid antibacterial agent of gram-positive bacteria and gram-negative bacteria, has strong inhibition effect on rickettsia, mycoplasma and chlamydia, and can inhibit certain spirochetes and protozoa. Clinically, minocycline hydrochloride can also be used for treating diseases such as plague, cholera, peptic ulcer caused by helicobacter pylori, inguinal granuloma caused by infection of granulomatous bacillus.
The traditional route for synthesizing minocycline hydrochloride generally comprises the steps of dechlorination, dehydroxylation, chlorination, diazotization, reduction, methylation and the like, and a palladium catalyst, a rhodium catalyst and hydrogen are needed for reaction, so that the steps are complex, and the material cost and the safety risk of production are high.
Patent CN103387512A discloses a two-step synthesis method of minocycline hydrochloride, which takes aureomycin hydrochloride as a raw material, and obtains minocycline hydrochloride through coupling reaction and debenzylation reaction. Meanwhile, the debenzylation step of the patent also uses a noble metal catalyst hydrogen reduction method, and even if the method is applied to production, the risk of hydrogen explosion also exists.
Disclosure of Invention
The technical problem to be solved by the invention is to provide a novel method for synthesizing minocycline hydrochloride, so that the synthesis steps are simplified, the safety risk and the labor hour cost are reduced, and the feasibility of converting the process into industrial mass production is improved.
The invention adopts the technical scheme that: a novel method for synthesizing minocycline hydrochloride, which comprises the following steps: A. taking the demethyl aureomycin hydrochloride as a raw material, and carrying out debenzylation reaction on the raw material to obtain 7-chloromountain cyclamine hydrochloride; B. 7-chloromountain cyclase hydrochloride, sodium iodide or potassium iodide are used as raw materials, and an ultraviolet irradiation method is used for synthesizing the 7-iodomountain cyclase hydrochloride; C. taking 7-iodo-shan-cycline hydrochloride and an organotin reagent as raw materials, and carrying out a coupling reaction under the action of a palladium complex to produce minocycline hydrochloride.
Further, the specific operation of the step A is as follows: adding hydrochloric acid demethyl aureomycin and dichlorodimethyl silane into sodium iodide or potassium iodide solution, reacting at 0-30 ℃ to remove benzyl hydroxyl of hydrochloric acid demethyl aureomycin, and then obtaining 7-chloromountain cyclic extract through acidification, crystallization, washing and drying.
Further, the specific operation of the step B is as follows: dissolving 7-chloromountain cyclamine hydrochloride and sodium iodide (potassium iodide) in a solvent, adding an acetonitrile solution of iodine for reaction, carrying out ultraviolet irradiation in an ultraviolet reactor at a low temperature of between 0 and 30 ℃ and with an ultraviolet wavelength of between 0 and 300nm, and acidizing, crystallizing, washing and drying after the reaction is finished to obtain the 7-iodomountain cyclamine.
Further, the specific operation of the step C is as follows: dissolving 7-iodo-mountain cyclamine hydrochloride in a reaction solvent, adding a palladium complex and an organotin reagent, performing a coupling reaction at a low temperature of 0-30 ℃, and separating by macroporous adsorption resin to obtain minocycline hydrochloride.
Further, in the step A, the chlortetracycline hydrochloride is prepared by: dichlorodimethylsilane: the molar ratio of potassium iodide or sodium iodide is 1 (1-2): 3-5, wherein the solvent used in the sodium iodide or sodium iodide solution in the step A is at least one of acetone and acetonitrile or a mixed solvent of one of acetone and acetonitrile and dichloromethane according to any proportion, and the mixed proportion of solute and solvent in the potassium iodide or sodium iodide solution is as follows: solvent=1:3 to 8 (g: mL).
Further, the ratio of the 7-chloromountain cyclic element to the solvent in the step B is 1:3-10 (g: mL), the solvent is acetonitrile or a mixed solvent of acetonitrile and water, the volume ratio of acetonitrile is 50% -100%, the ratio of sodium iodide (potassium iodide) to iodine solution is 2:1-2 (g: mL), the concentration of the iodine acetonitrile solution is 0.1-0.5M, and the molar ratio of the sodium iodide or potassium iodide to the 7-chloromountain cyclic element hydrochloride is 2-4:1.
Further, the solvent in the step C is one of ethylene glycol dimethyl ether, dimethylpropyleneurea, N-methylpyrrolidone, N-dimethylformamide, N-dimethylacetamide or 1, 4-dioxane, and the ratio of the 7-iodo-mountain bike hydrochloride to the solvent is 1:3 to 10 (g: mL); the palladium complex is one of diisopropylimidazole palladium chloride, tetra (triphenylphosphine) palladium, bis (triphenylphosphine) palladium dichloride or bis (acetonitrile) palladium dichloride; the organic tin reagent is an organic tin reagent with N, N-dimethyl connected with tin atoms, and is specifically one of 1, 1-tributyl-N, N-dimethyl stannane amine or (dimethyl amine) trimethyl tin; the molar ratio of the materials is 7-iodinated mountain cyclic acid hydrochloride: palladium complex catalyst: organotin reagent=1:0.01 to 0.05:1.03 to 1.2.
Further, the solvent used in the sodium iodide or potassium iodide solution in the step A is acetone.
Further, in the step B, the ultraviolet wavelength is 254nm, the reaction temperature is preferably 25 ℃, and the solvent for dissolving the 7-chloromountain cyclic element is a mixed solvent of acetonitrile and water in a ratio of 1:1.
Further, the solvent in the step C is N, N-dimethylformamide; the palladium complex is bis triphenylphosphine palladium dichloride; the organotin reagent is (dimethylamine) trimethyltin.
The beneficial effects obtained by the invention are as follows: the method simplifies the step of synthesizing minocycline hydrochloride, has no participation of hydrogen reduction reaction, improves the safety of the reaction, reduces the labor hour cost and improves the feasibility of industrialized mass production.
Drawings
FIG. 1 is a flow chart of a method for synthesizing minocycline hydrochloride according to the present invention.
Detailed Description
The following description of the embodiments of the present invention will be made clearly and completely, and it is apparent that the described embodiments are only some embodiments of the present invention, but not all embodiments.
Example 1
A. Synthesis of 7-chloromountain-Cycloxine hydrochloride
131.4g of sodium iodide is dissolved in 700mL of acetonitrile, the temperature is reduced to 0 ℃ under the protection of argon, 54mL of dichlorodimethylsilane and 110g of hydrochloric acid desmethylaureomycin are added into the stirred reaction solution to start the reaction, the reaction is monitored by TLC, saturated sodium thiosulfate solution is added for washing after the reaction is finished, and 103.1g of 7-chloromountain cyclidine hydrochloride is obtained through acidification, crystallization, washing and drying, and the single-step yield is 96.8%.
B. Synthesis of 7-iodo-shan-cycline hydrochloride
127.2g of sodium iodide was dissolved in 500mL of acetonitrile-water (volume ratio 1:1), 103.1g of 7-chloromountain cyclamine was added thereto, stirred until complete dissolution, and I was added dropwise2 Continuously stirring until the color is not changed, cooling in liquid nitrogen until the reaction liquid is completely frozen, vacuumizing by an oil pump, taking out the reaction bottle, placing in the air, slowly melting the feed liquid, replacing again, repeating the operation for 4 times, and finally filling argon. And (3) placing the reaction bottle into an ultraviolet irradiation reactor, irradiating with an ultraviolet lamp with the wavelength of 254nm at room temperature to initiate a reaction, monitoring the reaction by TLC, adding sodium thiosulfate to neutralize excessive iodine simple substance after the reaction is finished for 42 hours, and obtaining 100.1g of 7-iodo mountain cyclist through acidification, crystallization, washing and drying, wherein the single-step yield is 81.6%.
C. Synthesis of minocycline hydrochloride
100.1g of 7-iodo-shan-cycline is dissolved in 650mL of N, N-dimethylacetamide, 2.39g of tetra (triphenylphosphine) palladium is added, the mixture is stirred and dissolved at room temperature, 25mL of triethylamine, 61.2g of 1, 1-tributyl-N, N-dimethylstannanamine are added, the mixture is stirred at room temperature, TLC monitors the reaction, and after the reaction is finished, 62.0g of minocycline hydrochloride is obtained by eluting through macroporous adsorption resin, the single-step yield is 72.4%, and the total yield is 57.2%.
Example 2
A. Synthesis of 7-chloromountain-Cycloxine hydrochloride
178.5g of potassium iodide is dissolved in 550mL of acetone, the temperature is reduced to 0 ℃ under the protection of argon, 60mL of dichlorodimethylsilane and 108g of hydrochloric acid desmethylaureomycin are added into the stirred reaction solution to start the reaction, TLC monitors the reaction, saturated solution of sodium thiosulfate is added for washing after the reaction is finished, and 101.7g of 7-chloromountain cyclidine is obtained through acidification, crystallization, washing and drying, and the yield is 97.3%.
B. Synthesis of 7-iodo-shan-cycline hydrochloride
104.2g of potassium iodide is dissolved in 600mL of acetonitrile-water (volume ratio is 3:1), 101.7g of 7-chloromountain cyclic hydrochloride is added, stirring is carried out until the potassium iodide is completely dissolved, 60mL of acetonitrile solution of 0.3M iodine is dropwise added, stirring is continued until the color is not changed any more, a reaction bottle is placed into an ultraviolet irradiation reactor, ultraviolet irradiation with the wavelength of 254nm at room temperature is carried out for initiating reaction, TLC monitoring reaction is carried out, after 39h, sodium thiosulfate is added for neutralizing excessive iodine simple substance, 95.9g of 7-iodomountain cyclic hydrochloride is obtained through acidification, crystallization, washing and drying, and the yield is 79.2%.
C. Synthesis of minocycline hydrochloride
95.8g of 7-iodo-shan-cyclic acid hydrochloride is added to 700mLN, N-dimethylformamide, 1.9g of bis (triphenylphosphine) palladium dichloride is added, stirring and dissolving are carried out at room temperature, 20mL of triethylamine and 41.7g of 1, 1-trimethyl-N, N-dimethylstannanamine are added, stirring is carried out at room temperature, TLC monitoring reaction is carried out, and after the reaction is finished, 58.7g of minocycline hydrochloride is obtained through macroporous adsorption resin elution, crystallization, filtration, washing and drying, the yield is 71.5%, and the total yield is 55.1%.
Comparative examples:
A. synthesis of 7-dechlorinated desmethyl aureomycin hydrochloride
120g of desmethylaureomycin hydrochloride is added into 500mL of aqueous solution of urea at room temperature, the pH value is regulated to 8.5 by a sodium hydroxide solution, palladium carbon (Pd, wt percent and 5 percent) is added, hydrogen is introduced into a high-pressure reaction kettle at 0.95MPa and 25 ℃ for reaction, reaction feed liquid is treated after the reaction is finished, 107.5g of 7-dechlorinated desmethylaureomycin hydrochloride is obtained through acidification, crystallization, washing and drying, and the single-step yield is 96.1 percent.
B. Synthesis of mountain cyclic extract hydrochloride
At room temperature, after 7-dechlorinated and demethylated aureomycin hydrochloride 107.5g is dissolved in 400mL of methanol, 44.4g of methanesulfonic acid is added, stirring is carried out until the mixture is dissolved, rhodium-carbon Rh/C catalyst and DMF6.3mL are added, hydrogen is introduced into a high-pressure reaction kettle under the pressure of 1.50MPa at the temperature of 30 ℃ for reaction, the reaction liquid is treated after the reaction is finished, and 66.7g of the shancyclic hydrochloride is obtained through acidification, crystallization, washing and drying, and the single-step yield is 64.3%.
C. Synthetic intermediate 1
66.7g of mountain bike hydrochloride is dissolved in 200mL of purified water at 20 ℃, and after the mixture is stirred until the mixture is dissolved, 21.8g of chlorating reagent NCS is slowly added in batches at 25 ℃, and the mixture is stirred and reacted for 1h to obtain brown reaction liquid. The reaction feed liquid is treated, the temperature is controlled at 15-20 ℃, 56.8g of intermediate 1 is obtained through acidification, crystallization, washing and drying, and the single-step yield is 79.2%.
D. Preparation of diazonium salts
400mL of purified water, 30mL of concentrated hydrochloric acid and 40.7g of sulfanilic acid are sequentially added into a reaction kettle, 20mL of 40% sodium nitrite solution is slowly added dropwise at 0 ℃ for about 1 hour, the pH value is controlled below 3.0 by hydrochloric acid in the reaction process, and a white emulsion of diazonium salt is obtained after the reaction is finished.
E. Synthesis of intermediate 2
To the diazonium salt reaction solution was added a total of 56.8g of intermediate 1 in portions at 0℃and stirred for 1h. Slowly dripping 10% sodium carbonate solution at 0 ℃, adjusting the pH to 4.5-4.7, and stirring and reacting for 30min to obtain the hawthorn red emulsion. Continuously and slowly dripping saturated sodium bicarbonate solution at 0 ℃, regulating the pH value to 6.7-7.0, stirring and reacting for 1.5h to obtain a viscous dark brown emulsion, and obtaining 52.5g of intermediate 2 through acidification, crystallization, washing and drying, wherein the single-step yield is 84.3%.
F. Synthesis of minocycline hydrochloride
52.5g of intermediate 2 is dissolved in a mixed solvent of 50mL of ethylene glycol monomethyl ether, 50mL of concentrated sulfuric acid and 100mL of DMF at 15 ℃, the temperature is controlled below 25 ℃, and after uniform stirring, methanol solution of formaldehyde and formic acid is added. Transferring the feed liquid into an autoclave at 15 ℃, introducing hydrogen, reacting at 15 ℃ under 1.1Mpa under the catalysis of palladium-carbon, filtering and washing the reaction feed liquid after the reaction is finished, purifying by macroporous adsorption resin, crystallizing, washing and drying to obtain 38.3g of minocycline hydrochloride, wherein the single-step yield is 78.6%, and the total yield is 32.4%.
The foregoing is only a preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art, who is within the scope of the present invention, should make equivalent substitutions or modifications according to the technical scheme of the present invention and the inventive concept thereof, and should be covered by the scope of the present invention.

Claims (9)

CN202110988351.8A2021-08-262021-08-26Novel method for synthesizing minocycline hydrochlorideActiveCN113717073B (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN202110988351.8ACN113717073B (en)2021-08-262021-08-26Novel method for synthesizing minocycline hydrochloride

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN202110988351.8ACN113717073B (en)2021-08-262021-08-26Novel method for synthesizing minocycline hydrochloride

Publications (2)

Publication NumberPublication Date
CN113717073A CN113717073A (en)2021-11-30
CN113717073Btrue CN113717073B (en)2023-11-14

Family

ID=78678218

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN202110988351.8AActiveCN113717073B (en)2021-08-262021-08-26Novel method for synthesizing minocycline hydrochloride

Country Status (1)

CountryLink
CN (1)CN113717073B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN1450989A (en)*2000-07-072003-10-22塔夫茨大学信托人7-substituted tetracycline compounds
AU2005204259A1 (en)*1999-09-142005-09-22Trustees Of Tufts CollegeMethods of preparing substituted tetracyclines with transition metal-based chemistries
CN106831479A (en)*2017-02-062017-06-13福建省微生物研究所A kind of preparation method of minocycline hydrochloride
CN111362825A (en)*2020-04-012020-07-03宁波天泽新材料科技有限公司 A kind of preparation technology of 6-desmethyl-6-deoxytetracycline
CN112574057A (en)*2021-01-252021-03-30南京仁为医药科技有限公司Method for synthesizing minocycline hydrochloride

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
AU2005204259A1 (en)*1999-09-142005-09-22Trustees Of Tufts CollegeMethods of preparing substituted tetracyclines with transition metal-based chemistries
CN1450989A (en)*2000-07-072003-10-22塔夫茨大学信托人7-substituted tetracycline compounds
CN106831479A (en)*2017-02-062017-06-13福建省微生物研究所A kind of preparation method of minocycline hydrochloride
CN111362825A (en)*2020-04-012020-07-03宁波天泽新材料科技有限公司 A kind of preparation technology of 6-desmethyl-6-deoxytetracycline
CN112574057A (en)*2021-01-252021-03-30南京仁为医药科技有限公司Method for synthesizing minocycline hydrochloride

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
A Convenient Procedure for the Reduction of Diarylmethanols with Dichlorodimethylsilane/Sodium Iodide;J. Mark Wiggins et al.;《SYNTIIETIC COMMJNICATIONS》;第18卷(第7期);第741-749页*
Photo-induced metal-catalyst-free aromatic finkelstein reaction;Lu Li et al.;《J. Am. Chem. Soc.》;第137卷;第8328-8331页*
Wataru Ando et al..A NOVEL REDUCTION OF α-ARYL ALEANOLS BY DIIODODIMETHYLSILANE.《Tetrahedron Letters》.1979,(第51期),第4941-4942页.*
曾昭琼等.《有机化学》.高等教育出版社,1979,第238-240页.*

Also Published As

Publication numberPublication date
CN113717073A (en)2021-11-30

Similar Documents

PublicationPublication DateTitle
CN111704555B (en)Method for synthesizing 4-methoxy-2-nitroaniline by adopting continuous flow reactor
CN112094194A (en)Method for controlling TOC in waste brine in DAM production process
CN107556302B (en)Method for preparing empagliflozin
CN111004162B (en) A kind of method and device for preparing L-selenocystine with sodium triacetoxyborohydride as reducing agent
CN111349049A (en)Favipiravir and synthesis process of intermediate thereof
CN110372526A (en)A kind of preparation method of 3- methyl-2-amino benzoic acid
CN112778147A (en)Preparation method of 2-amino-3-methyl-5-chlorobenzoic acid
CN113717073B (en)Novel method for synthesizing minocycline hydrochloride
CN114957193A (en)Method for green synthesis of vinylene carbonate
JP2007261976A (en)Method for producing antineoplastic anthracycline-based antibiotic
CN100522923C (en)Preparation method of 2-bromo-2-nitro-1,3-propylene glycol
CN114409623A (en)Method for preparing baroxavir intermediate
WO2022067747A1 (en)Method for controlling toc in effluent brine in dam production process
CN109134563B (en)Catalytic synthesis process of methylamino abamectin key intermediate
CN103044272B (en)Preparation method of 4-nitroso-N-ethyl-N-hydroxyethyl aniline
CN104974061A (en)Preparation method of balsalazide disodium
CN114989074A (en)Preparation method of sodium picosulfate
CN108752184A (en)A kind of preparation method of SGLT2 inhibitor intermediate
CN116396226A (en)Preparation method of agoraphobia and intermediate compound thereof
CN108164423A (en)A kind of preparation method of naftifine hydrochloride
KR890001850B1 (en)Process for the preparation of benzidine compound
CN118459392A (en)Preparation method of 5-aminolevulinic acid hydrochloride intermediate
JP2762591B2 (en) Method for producing isopropyl alcohol
US6262304B1 (en)Process for producing dimethylcyanamide
CN112679359B (en)Preparation method of bronopol

Legal Events

DateCodeTitleDescription
PB01Publication
PB01Publication
SE01Entry into force of request for substantive examination
SE01Entry into force of request for substantive examination
GR01Patent grant
GR01Patent grant

[8]ページ先頭

©2009-2025 Movatter.jp